Financial Perspectives’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Hold
1,774
0.07% 146
2026
Q1
$271K Hold
1,774
0.08% 138
2025
Q4
$245K Hold
1,774
0.07% 145
2025
Q3
$227K Hold
1,774
0.06% 147
2025
Q2
$215K Hold
1,774
0.06% 142
2025
Q1
$198K Hold
1,774
0.07% 141
2024
Q4
$173K Hold
1,774
0.06% 151
2024
Q3
$204K Buy
1,774
+574
+48% +$65.1K 0.07% 137
2024
Q2
$128K Hold
1,200
0.05% 176
2024
Q1
$116K Sell
1,200
-33
-3% -$3.38K 0.04% 186
2023
Q4
$124K Hold
1,233
0.05% 176
2023
Q3
$126K Hold
1,233
0.06% 162
2023
Q2
$124K Hold
1,233
0.05% 161
2023
Q1
$113K Hold
1,233
0.05% 168
2022
Q4
$112K Hold
1,233
0.06% 162
2022
Q3
$93.7K Hold
1,233
0.05% 174
2022
Q2
$104K Hold
1,233
0.06% 167
2022
Q1
$108K Hold
1,233
0.05% 183
2021
Q4
$108K Sell
1,233
-523
-30% -$43.4K 0.05% 168
2021
Q3
$144K Sell
1,756
-3,005
-63% -$270K 0.07% 145
2021
Q2
$434K Hold
4,761
0.21% 75
2021
Q1
$407K Buy
4,761
+300
+7% +$26.9K 0.22% 73
2020
Q4
$421K Buy
4,461
+111
+3% +$9.7K 0.24% 65
2020
Q3
$378K Hold
4,350
0.25% 58
2020
Q2
$380K Buy
4,350
+285
+7% +$24.6K 0.27% 53
2020
Q1
$335K Buy
4,065
+112
+3% +$9.99K 0.27% 47
2019
Q4
$374K Buy
+3,953
New +$355K 0.26% 50

Other funds holding NVS

Financial Perspectives's NVS Position: Q2 2026 in Review

Financial Perspectives held its Novartis (NVS) position steady in Q2 2026 at 1,774 shares worth $278K. The position accounts for 0.07% of the portfolio, ranked #146.

Financial Perspectives first reported a position in NVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $434K in Q2 2021. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Financial Perspectives held 1,774 shares of Novartis worth $278K as of Q2 2026.
  • Financial Perspectives left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.07% of Financial Perspectives's portfolio in Q2 2026, its #146 holding.
  • Financial Perspectives first reported a position in Novartis in Q4 2019 and has held it in 27 quarters since.
  • Financial Perspectives's Novartis position peaked at $434K in Q2 2021.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.